You are here: Industry Insights > Transcenta

News List

Transcenta Announced Successful First Patient Dosed in Phase I Clinical Study of TST001 Combined with CAPOX for the Treatment of Patients with First-line Locally Advanced Unresectable or Metastatic Ga prnasia
April 19, 2021
Transcenta Holding Limited (Transcenta), a clinical stage global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, today announced the first patient has been ...
Transcenta Announces Appointments of Dr. Xichen Zhang as Senior Vice President of Manufacturing and Dr. Steven Yu as Senior Vice President of DMPK and Translational Science prnasia
March 24, 2021
Transcenta today announced the expansion of its senior management team by appointing Dr. Xichen Zhang as Senior Vice President of Manufacturing and Dr. Steven Yu as Senior Vice President of DMPK & Translational Science.
Transcenta Closes $105 Million in Crossover Financing prnasia
December 23, 2020
Transcenta Holding Limited, a global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, announces today the completion of a 105 million USD crossover financing.
Transcenta Holding Secures $100 Million Series B Plus Financing prnasia
January 09, 2020
Mr. Shen Qi, Senior Vice President and Head of Healthcare Investment at Fortune Capital, said "We appreciate having the chance to support Transcenta team in this financing round together with the other investors.

Previous page 1 2 Next page